|
|
|
| home > white papers > Blockbuster Drugs Need Blockbuster Components - West Pharmaceutical Services, Inc. |
|
|
 WHITE PAPERS |
|
West Pharmaceutical Services, Inc.
|
|
Blockbuster Drugs Need Blockbuster Components
|
|
Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
eTheRNA Announces Research Agreement With Merck KGaA, Darmstadt, Germany to Access mRNA Technologies
NIEL, Belgium, Feb. 3, 2022 /PRNewswire/ -- eTheRNA immunotherapies
NV ("eTheRNA") is pleased to announce the start of a strategic
partnership with Merck KGaA, Darmstadt, Germany with the signing of a
Research Agreement. The partnership will investigate the application of
eTheRNA's proprietary mRNA design expertise and LNP-delivery platforms
to disease areas selected by Merck KGaA, Darmstadt, Germany.
More info >> |
|
 |
White Papers |
 |
|
Soothing the Logistical Headache of Clinical Trials
Equilibrium Travel Management
As many as 30 per cent of subjects on phase three clinical studies drop out. Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial. It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >> |
|
|
|
